Dynamic Arterial Elastance During General Anesthesia Induction

March 23, 2020 updated by: Abele Donati, MD, Università Politecnica delle Marche

Dynamic Arterial Elastance as Predictive Parameter of Hypotension During General Anesthesia Induction.

This study evaluates if dynamic arterial elastance measured before general anesthesia induction can predict the occurrence of hypotension due to general anesthesia induction.

Study Overview

Status

Unknown

Conditions

Detailed Description

As general anesthetics may be responsible for vasodilation and cardiac depression, arterial hypotension after induction of general anesthesia is a common event and may contribute to an adverse outcome. Dynamic arterial elastance has been proposed as a functional parameter of arterial tone and studies showed that it was able to predict pressure response to fluid administration in fluid-responsive patients and the amount of mean arterial pressure riduction as a conseguence of noradrenaline dose reduction in critically ill patients.

Study Type

Observational

Enrollment (Anticipated)

65

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Ancona, Italy
        • Recruiting
        • Azienda Ospedaliero Universitaria Ospedali Riuniti Ancona
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Patients undergone to general anesthesia for surgery that need mini-invasive cardiac output monitoring.

Description

Inclusion Criteria:

  • Patients that will be undergone to general anesthesia for surgery
  • Patients that need mini-invasive cardiac output monitoring during surgery

Exclusion Criteria:

  • Age <18 yo
  • Pregnancy
  • Arrhythmia
  • Severe valvular diseases
  • Uncorrectable alterations of arterial signal

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Baseline value of Eadyn as predictor of hypotension occurrence due to general anesthesia induction
Time Frame: From baseline (before general anesthesia induction) up to 30 minutes.
Dynamic arterial elastance (Eadyn) will be recorded at baseline before induction of general anesthesia. Mean arterial pressure (MAP) will be recorded at baseline and continuously until tracheal intubation. The lowest value of MAP will be considered to define hypotension occurrence.
From baseline (before general anesthesia induction) up to 30 minutes.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Correlation between Eadyn and severity of hypotension due to anesthesia induction
Time Frame: From baseline (before general anesthesia induction) up to 30 minutes.
To evaluate the correlation between the baseline value of Eadyn and the severity of hypotension when it will occur after induction of general anesthesia
From baseline (before general anesthesia induction) up to 30 minutes.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Abele Donati, MD, PhD, Università Politecnica delle Marche

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 10, 2019

Primary Completion (Anticipated)

July 1, 2020

Study Completion (Anticipated)

April 1, 2021

Study Registration Dates

First Submitted

April 4, 2019

First Submitted That Met QC Criteria

April 8, 2019

First Posted (Actual)

April 10, 2019

Study Record Updates

Last Update Posted (Actual)

March 25, 2020

Last Update Submitted That Met QC Criteria

March 23, 2020

Last Verified

March 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • CLRIA-AC01

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anesthesia

3
Subscribe